J. Fischer

发表

Lack of serious toxicity following gabapentin overdose

V. Trudeau, J. Fischer, A. Ban, 1994, Neurology.

Pharmacokinetics of 17 alpha hydroxyprogesterone caproate in singleton pregnancy and its influence of maternal body size measures.

L. Digiovanni, C. Enakpene, J. Fischer, 2019, American journal of obstetrics & gynecology MFM.

Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy

T. Jenkins, S. Kilpatrick, L. Endres, 2014, Clinical Pharmacokinetics.

Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age

S. Kilpatrick, M. Habibi, G. Sarto, 2011, Antimicrobial Agents and Chemotherapy.

Influence of Body Weight, Ethnicity, Oral Contraceptives and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Child-Bearing Age Running Title: Pharmacokinetics of Azithromycin in Pregnancy

G. Sarto, J. Fischer, 2011 .

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Effects of Regulatory Support Services on Institutional Review Board Turnaround Times

T. Johnson, J. Fischer, P. Desai, 2017, Journal of empirical research on human research ethics : JERHRE.

Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates.

G. Kondos, J. Fischer, R. Barbarash, 1988, Chest.

Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics.

Hyunyoung Jeong, J. Hibbard, J. Fischer, 2010, American journal of obstetrics and gynecology.

Up-Regulation of UDP-Glucuronosyltransferase (UGT) 1A4 by 17β-Estradiol: A Potential Mechanism of Increased Lamotrigine Elimination in Pregnancy

Hyunyoung Jeong, J. Fischer, Kyunghee Yang, 2009, Drug Metabolism and Disposition.

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Efficacy and Tolerability of the New Antiepileptic Drugs , II : Treatment of Refractory Epilepsy : Report of the TTA and QSS

B. Bourgeois, W. Marks, J. Stern, 2004 .

Pharmacokinetics of Intravaginal Metronidazole Gel

L. Brubaker, J. Fischer, F. Cunningham, 1994, Journal of clinical pharmacology.

Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors

J. Zacny, N. Venepalli, A. Dudek, 2019, American journal of clinical oncology.

Reversal of the Electrocardiographic Effects of Cocaine by Lidocaine. Part 2. Concentration‐Effect Relationships

R. Hariman, J. Fischer, J. Bauman, 1994, Pharmacotherapy.

Inﬂuence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age

S. Kilpatrick, M. Habibi, G. Sarto, 2012 .

Simulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 Patients

J. Rotschafer, J. Fischer, K. Rodvold, 1989, Pharmacotherapy.

Alterations in theophylline metabolism during the first year of life

K. Mcculloch, T. Yeh, J. Fischer, 1993, Clinical pharmacology and therapeutics.

Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination

J. Fischer, H. Chen, H. Jeong, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

Serum haloperidol concentration and choreiform movements in Huntington's disease

A. Singhal, A. Barr, J. Fischer, 1988, Neurology.

Volume of distribution of theophylline in acute exacerbations of reversible airway disease. Effect of body weight.

M. Zell, J. Fischer, W. G. Troyer, 1985, Chest.

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies

M. Nicholas, T. Tarasow, T. Fan, 2015, British Journal of Cancer.

Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy

J. Fischer, J. Cloyd, R. Kriel, 1983 .

Vancomycin pharmacokinetics in patients with various degrees of renal function

J. Rotschafer, J. Fischer, K. Rodvold, 1988, Antimicrobial Agents and Chemotherapy.

Phenobarbital maintenance dose requirements in treating neonatal seizures

L. Lockman, J. Fischer, D. Zaske, 1981, Neurology.

Increased vancomycin dosage requirements in young burn patients

J. Rotschafer, G. Bailie, B. Ackerman, 1984 .

Stability of nizatidine in commonly used intravenous fluids and containers.

J. Fischer, K. Rodvold, M. Cwik, 1988, American journal of hospital pharmacy.

The pharmacokinetics of dexamethasone in the thoroughbred racehorse.

R. Jensen, F. Cunningham, J. Fischer, 1996, Journal of veterinary pharmacology and therapeutics.

Evaluation of Topical Metronidazole Gel in Acne Rosacea

J. Fischer, Dennis P. West, F. Paloucek, 1987, Drug intelligence & clinical pharmacy.

Bioavailability of Total and Unbound Disopyramide: Implications for Clinical Use of the Immediate and Controlled‐Release Dosage Forms

J. Fischer, M. Schoen, J. Bauman, 1994, Journal of clinical pharmacology.

Gabapentin: A New Agent for the Management of Epilepsy

J. Fischer, Carlota O. Andrews, 1994, The Annals of pharmacotherapy.

Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

J. Fischer, Tejal Patel, Patricia A. Fischer, 2003, Clinical pharmacokinetics.

Nizatidine Suppression of Basal Gastric Acid Output: A Comparison of Two Intravenous Dosage Regimens

L. Danziger, J. Fischer, Kevin M. Furmaga, 1989, Journal of clinical pharmacology.

Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance

J. Fischer, J. Cloyd, R. Kriel, 1993, Clinical pharmacology and therapeutics.

CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Pharrnacokinetics of valproic acid in children

J. Fischer, J. Cloyd, R. Kriel, 1983, Neurology.

Effect of food on the serum concentration profile of entericcoated valproic acid

A. Barr, J. Fischer, F. Paloucek, 1988, Neurology.

Phase I Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

R. Bliss, A. Dudek, J. Fischer, 2016, American journal of clinical oncology.

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy

E. Wiley, G. Thatcher, R. O'Regan, 2020, Breast Cancer Research and Treatment.

Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

R. Emmadi, N. Venepalli, A. Dudek, 2019, American journal of clinical oncology.

Evaluation of Transdermal Theophylline Pharmacokinetics in Neonates

G. Micali, J. Fischer, L. Solomon, 1993, Pharmacotherapy.

Valproic acid pharmacokinetics in children. II.

J. Fischer, J. Cloyd, R. Kriel, 1985, Neurology.

Therapeutic Monitoring and Pharmacist Intervention in a Hansen's Disease Clinic

J. D. Robinson, D. West, S. Piscitelli, 1993, The Annals of pharmacotherapy.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Discontinuation of concomitant antiepileptic drug therapy

J. Fischer, J. Cloyd, R. Kriel, 2006 .

Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin.

A. Lau, J. Fischer, P. How, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Quantitative determination of tolazoline in serum and urine.

J. Fischer, M. Cwik, B. Currie, 1985, Journal of chromatography.

Incidence of Intravenous Site Reactions in Neurotrauma Patients Receiving Valproate or Phenytoin

H. Winn, N. Temkin, G. Anderson, 2000, The Annals of pharmacotherapy.

The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials

B. Wilfond, A. Caplan, J. Fischer, 2015, Clinical trials.

Valproic acid pharmacokinetics in children: III. Very high dosage requirements.

G. Fraser, J. Fischer, J. Cloyd, 1986, Pediatric neurology.

Lack of Effect of Nizatidine‐Induced Elevation of Gastric pH on the Oral Bioavailability of Dapsone in Healthy Volunteers

L. Danziger, J. Fischer, P. Manitpisitkul, 2002, Pharmacotherapy.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites

P. Angeli, J. Bajaj, G. Garcia‐Tsao, 2022, GastroHep.

Stability of Fosphenytoin Sodium with Intravenous Solutions in Glass Bottles, Polyvinyl Chloride Bags, and Polypropylene Syringes

J. Fischer, M. Cwik, Mark S Luer, 1997, The Annals of pharmacotherapy.

Effect of age and training status on pharmacokinetics of flunixin meglumine in thoroughbreds.

R. Jensen, J. Fischer, M. Cwik, 1990, American journal of veterinary research.

Evaluation of a continual compliance monitoring program for dapsone in an outpatient Hansen's disease clinic.

D. West, J. Fischer, S. Worobec, 1986, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

The influence of serum albumin and alpha 1-acid glycoprotein on vancomycin protein binding in patients with burn injuries.

J. Rotschafer, J. Fischer, K. Rodvold, 1989, The Journal of burn care & rehabilitation.

Pharmacokinetic Evaluation of Two Theophylline Dosing Methods for Infants

J. Fischer, D. M. Kraus, Fotini K. Hatzopoulos, 1994, Therapeutic drug monitoring.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures

J. Sackellares, B. Uthman, A. Beydoun, 1997, Neurology.

Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2007 .

J. Fischer, Tejal Patel, Patricia A. Fischer, 2003, Clinical pharmacokinetics.

Saturable transport of gabapentin at the blood-brain barrier.

C. Hamani, M. Dujovny, J. Fischer, 1999, Neurological research.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.